
5th AnnualInvitation Only
Cell Therapy & Bispecifics
USFocus Meeting 2027
Two days, 52 people, one room.
March 5 to 6, 2027
Kimpton Marlowe, Boston, MA
Dates
March 5-6, 2027
Two-day program
Venue
Kimpton Marlowe
Boston, MA
Audience
52 by invitation
26 KOLs & 26 fellows
Format
8 sessions · 24 talks
Expert talks + moderated panels
A Curated Room: The People Shaping Practice
Now in its fifth year, this invitation-only meeting convenes a deliberately small faculty: 26 leading cell therapy and bispecific KOLs alongside 26 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.
The science tracks where treatment is moving: CAR T pushed earlier into first remission, T-cell engagers reshaping myeloma, and the sequencing questions that surface when one modality fails. Every session pairs expert talks with a moderated panel and a case presentation, sustained, close-quarters engagement rather than a lecture hall.
CAR T for ALL in CR1T-Cell Engagers in Multiple MyelomaCAR T in Multiple MyelomaSequencing CAR T & TCEsCAR T in R/R ALLAcute Lymphoblastic Leukemia · Myeloma
Meeting Co-Chairs
Listed alphabetically by surname

Nitin Jain
MD Anderson Cancer Center, Houston, TX

Sattva Neelapu
MD Anderson Cancer Center, Houston, TX

Noopur Raje
Massachusetts General Hospital, Boston, MA
Faculty Drawn From
MD Anderson · Stanford · Dana-Farber · City of Hope · Moffitt · Mass General Brigham and other leading US cancer centers
52
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
Cell Therapy & Bispecifics US Focus Meeting 2027
Confirmed Faculty
Listed alphabetically by surname
Ibrahim Aldoss
City of Hope, Duarte, CA
Dai Chihara
MD Anderson Cancer Center, Houston, TX
Noelle Frey
University of Pennsylvania, Philadelphia, PA
Matt Frigault
Massachusetts General Hospital, Boston, MA
Mark Hamilton
MD Anderson Cancer Center, Houston, TX
Elias Jabbour
MD Anderson Cancer Center, Houston, TX
Sundar Jagannath
Icahn School of Medicine at Mount Sinai, New York, NY
Nitin Jain
MD Anderson Cancer Center, Houston, TX
Amrita Krishnan
City of Hope, Duarte, CA
Yi Lin
Mayo Clinic, Rochester, MN
Marlise Luskin
Dana-Farber Cancer Institute, Boston, MA
Marcela Maus
Massachusetts General Hospital, Boston, MA
David Miklos
Stanford Medicine, Stanford, CA
Kevin Miller
Mass General Brigham Cancer Institute, Boston, MA
Sattva Neelapu
MD Anderson Cancer Center, Houston, TX
Jae Park
Memorial Sloan Kettering Cancer Center, New York, NY
Noopur Raje
Massachusetts General Hospital, Boston, MA
Surbhi Sidana
Stanford Medicine, Stanford, CA
Andrew Yee
Massachusetts General Hospital, Boston, MA
Eight Sessions
Proposed Faculty by Session
CAR-T for ALL in CR1. This Is the Future?
Moderator
Ibrahim AldossCity of Hope, Duarte, CA
Jae ParkMemorial Sloan Kettering Cancer Center, New York, NY
Elias JabbourMD Anderson Cancer Center, Houston, TX
T Cell Engagers in Multiple Myeloma
Moderator
Amrita KrishnanCity of Hope, Duarte, CA
Andrew YeeMassachusetts General Hospital, Boston, MA
Kevin MillerMass General Brigham Cancer Institute, Boston, MA
Sequencing CAR-T & TCEs + Post-Failure Treatment
Moderator
Sundar JagannathIcahn School of Medicine at Mount Sinai, New York, NY
Keynotes
Moderator
David MiklosStanford Medicine, Stanford, CA
Marcela MausMassachusetts General Hospital, Boston, MA
CAR-T in R/R ALL
Moderator
Noelle FreyUniversity of Pennsylvania, Philadelphia, PA
Marlise LuskinDana-Farber Cancer Institute, Boston, MA
CAR-T Cells in Multiple Myeloma
Moderator
Yi LinMayo Clinic, Rochester, MN
Matt FrigaultMassachusetts General Hospital, Boston, MA
Surbhi SidanaStanford Medicine, Stanford, CA
CAR-T for Lymphoma
Moderator
Mark HamiltonMD Anderson Cancer Center, Houston, TX
TCEs for Lymphoma
Moderator
Dai ChiharaMD Anderson Cancer Center, Houston, TX
Partnership Opportunities Now Open
Bespoke engagement packages for a closed, invitation-only audience
Request the Prospectus →

Your Point of Contact
Tania Lifanova
Account Executive, MD Education
tania.lifanova@md-education.com
